雷帕鸣的适应症

Indications of Biocon India: Biocon Rapamin India is a generic drug. Biocon is a global biopharmaceutical company that believes everyone has the right to affordable, high-quality medicines. From assembly line to production, from drug development to drug delivery, we bring differentiated, high-quality and affordable medical products to communities around the world. The indications of India's Biocanrepamin are the same as the original drug, and it is used to treat patients aged 13 or above who have received kidney transplants to prevent organ rejection. Recommended for use in combination with cyclosporine and corticosteroids.

Rapamide is available in tablets, capsules, oral solution and other dosage forms. As a prescription drug, Rapamin is only for use by physicians experienced in immunosuppressive therapy and in the management of kidney transplant patients. Patients should not take medication blindly. Tablet usage is as follows: The recommended loading dose for kidney transplant patients is 6 mg and the maintenance dose is 2 mg/day. Lepa Ming can be taken with or without food. Rapamin tablets need to be swallowed whole and not chewed or crushed. If the patient has difficulty swallowing, an oral solution should be chosen. If dosage adjustment is necessary, this should be done on the advice of a physician. Overdosing can cause some additional side effects.

Common side effects of Biocanrapamine in India include thrombocytopenia, fever, anemia, hypokalemia, hypophosphatemia, urinary tract infection, hypercholesterolemia, hypertension, hyperglycemia, hypertriglyceridemia, pain, arthralgia, acne, peripheral edema, lymphocele, diarrhea, abdominal pain, constipation, headache, nausea, elevated serum creatinine levels, and elevated blood lactate dehydrogenase levels (LDH). Since each patient's physical condition is different, if you experience serious side effects while taking the medication, please contact your doctor in time.

The above is the introduction of the indications of Biocon in India. I hope it will be helpful to you.

Recommended related hot articles: /newsDetail/86865.html